Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001753926-25-000576
Filing Date
2025-04-04
Accepted
2025-04-04 12:00:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 30408
  Complete submission text file 0001753926-25-000576.txt   32285
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Subject) CIK: 0001427570 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-89741 | Film No.: 25812610
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 256 WEST 38TH STREET 15TH FLOOR NEW YORK NY 10018
Business Address 256 WEST 38TH STREET 15TH FLOOR NEW YORK NY 10018 2127854680
Dominion Capital LLC (Filed by) CIK: 0001532798 (see all company filings)

EIN.: 452571126 | State of Incorp.: CT | Fiscal Year End: 1231
Type: SCHEDULE 13D/A